Home

arv Artist slem overall survival neuroblastoma affix sanning mikroskopisk

Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late  Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis
Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis

A deeper look at the recent DFMO paper... - Beat Childhood Cancer
A deeper look at the recent DFMO paper... - Beat Childhood Cancer

Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma  in Germany 1979–2015 | Pediatric Drugs
Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015 | Pediatric Drugs

Association of image‐defined risk factors with clinical features,  histopathology, and outcomes in neuroblastoma - Temple - 2021 - Cancer  Medicine - Wiley Online Library
Association of image‐defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma - Temple - 2021 - Cancer Medicine - Wiley Online Library

Development and validation of a postoperative nomogram for predicting overall  survival after endoscopic surgical management of olfactory neuroblastoma -  eClinicalMedicine
Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma - eClinicalMedicine

Neuroblastoma - ScienceDirect
Neuroblastoma - ScienceDirect

A practical nomogram and risk stratification system for predicting survival  outcomes in neuroblastoma patients: a SEER population-based study | Journal  of Cancer Research and Clinical Oncology
A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study | Journal of Cancer Research and Clinical Oncology

Unchanged incidence and increased survival in children with neuroblastoma  in Denmark 1981–2000: a population-based study | British Journal of Cancer
Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981–2000: a population-based study | British Journal of Cancer

Kaplan–Meier overall survival curves for patients with neuroblastoma... |  Download Scientific Diagram
Kaplan–Meier overall survival curves for patients with neuroblastoma... | Download Scientific Diagram

Kaplan–Meier overall survival curves for patients with neuroblastoma,... |  Download Scientific Diagram
Kaplan–Meier overall survival curves for patients with neuroblastoma,... | Download Scientific Diagram

Kaplan–Meier overall survival curves for patients with neuroblastoma... |  Download Scientific Diagram
Kaplan–Meier overall survival curves for patients with neuroblastoma... | Download Scientific Diagram

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children  With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN  BEACON-Neuroblastoma Trial | Journal of Clinical Oncology
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial | Journal of Clinical Oncology

A single center clinical analysis of children with neuroblastoma
A single center clinical analysis of children with neuroblastoma

Neuroblastoma - TeachMePaediatrics
Neuroblastoma - TeachMePaediatrics

Neuroblastoma | Radiology Key
Neuroblastoma | Radiology Key

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy,  Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic  Acid | NEJM
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid | NEJM

Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence  and improved survival of high-risk neuroblastoma - ScienceDirect
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - ScienceDirect

Effectiveness of screening for neuroblastoma at 6 months of age: a  retrospective population-based cohort study - The Lancet
Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet

Survival curves of patients with neuroblastoma according to expression... |  Download Scientific Diagram
Survival curves of patients with neuroblastoma according to expression... | Download Scientific Diagram

Treatment and outcomes of 1041 pediatric patients with neuroblastoma who  received multidisciplinary care in China | Pediatric Investigation
Treatment and outcomes of 1041 pediatric patients with neuroblastoma who received multidisciplinary care in China | Pediatric Investigation

Long term outcome of high-risk neuroblastoma patients after immunotherapy  with antibody ch14.18 or oral metronomic chemotherapy | BMC Cancer | Full  Text
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy | BMC Cancer | Full Text

A single center clinical analysis of children with neuroblastoma
A single center clinical analysis of children with neuroblastoma

Overall survival of neuroblastoma patients depending on the N-Myc... |  Download Scientific Diagram
Overall survival of neuroblastoma patients depending on the N-Myc... | Download Scientific Diagram

Prognostic significance of MYCN related genes in pediatric neuroblastoma: a  study based on TARGET and GEO datasets | BMC Pediatrics | Full Text
Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets | BMC Pediatrics | Full Text

Event‐free survival (A) and overall survival curves (B) for patients... |  Download Scientific Diagram
Event‐free survival (A) and overall survival curves (B) for patients... | Download Scientific Diagram

Kaplan–Meier curves for neuroblastoma patients with and without TIAM1... |  Download Scientific Diagram
Kaplan–Meier curves for neuroblastoma patients with and without TIAM1... | Download Scientific Diagram

Progression-Free Survival and Patterns of Response in Patients With  Relapsed High-Risk Neuroblastoma Treated With  Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage  Colony-Stimulating Factor | Journal of Clinical Oncology
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor | Journal of Clinical Oncology

Neuroblastoma Treatment and Clinical Trials
Neuroblastoma Treatment and Clinical Trials

Prognostic significance of MYCN related genes in pediatric neuroblastoma: a  study based on TARGET and GEO datasets | BMC Pediatrics | Full Text
Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets | BMC Pediatrics | Full Text